abx ABX464
- 公司名稱(chēng) MedChemExpress LLC
- 品牌 MedChemExpress (MCE)
- 型號(hào) abx
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2019/6/26 9:15:25
- 訪問(wèn)次數(shù) 703
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息，謝謝!
MedChemExpress (MCE) 專(zhuān)注于為科學(xué)家提供高品質(zhì)的生物活性小分子化合物，化合物庫(kù)及各類(lèi)試劑盒，總部位于美國(guó)新澤西。
• MedChemExpress (MCE) 產(chǎn)品作用于 20 多個(gè)熱門(mén)信號(hào)通路及研究領(lǐng)域的300多個(gè)細(xì)分靶點(diǎn)，擁有 10000 特異性抑制劑、激動(dòng)劑，以及 50 活性化合物篩選庫(kù)；
• 我們堅(jiān)持對(duì)所有產(chǎn)品進(jìn)行嚴(yán)格質(zhì)檢，確保產(chǎn)品的高品質(zhì)和高純度；
• MedChemExpress (MCE) 產(chǎn)品已被數(shù)萬(wàn)名科學(xué)家信賴(lài)，并被大量top文獻(xiàn)和*引用；
• 我們擁有專(zhuān)業(yè)的技術(shù)團(tuán)隊(duì)追蹤前沿科研進(jìn)展，不斷豐富各個(gè)靶點(diǎn)的特異性產(chǎn)品，堅(jiān)持做 “您身邊的抑制劑大師”；
• MedChemExpress (MCE) 與眾多藥企和科研機(jī)構(gòu)保持深度合作；
• 大量產(chǎn)品有中國(guó)庫(kù)存，工作日 16:00 前訂單確保當(dāng)日發(fā)貨，次日送達(dá)。
MCE 中國(guó)站：www.MedChemExpress.cn
Hotline: 400-820-3792
Tel: 021-58955995
Email: sales@MedChemExpress.cn
Tech Support: 021-58950656
抑制劑，調(diào)節(jié)劑，API，天然產(chǎn)物，各種類(lèi)型化合物庫(kù)
| 供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10 mM * 1 mL；1 mg；5 mg；10 mg；25 mg；50 mg |
|---|---|---|---|
| 貨號(hào) | HY-100870 | 應(yīng)用領(lǐng)域 | 生物產(chǎn)業(yè) |
ABX464
產(chǎn)品活性：ABX464 是一種有效的抗 HIV 劑。ABX464 作用于受刺激的外周血單個(gè)核細(xì)胞 (PBMCs)，抑制 HIV-1 復(fù)制，IC50 為 0.1 μM 至 0.5 μM。
研究領(lǐng)域：Anti-infection
作用靶點(diǎn)：HIV
In Vitro: ABX464 inhibits HIV-1 production in PBMC- and macrophages-infected cells. ABX464 has a strong inhibitory effect for all HIV-1 subtypes tested including subtype B, C and recombinant viruses. ABX464 also very efficiently inhibits the replication of viral strains harbouring mutations that confer resistance to different therapeutic agents in vitro. While the antiviral drug 3TC is not highly active on K65R and M184V mutant strains, both strains are inhibited by ABX464. To generalize the effect of ABX464 on HIV-1 replication in other primary cells, cells are treated with between 0.01 μM up to 30 μM concentrations of ABX464 and p24 antigen levels are monitored in culture supernatants over a 12 days period. ABX464 efficiently blocks virus replication in a dose-dependent manner with an IC50 ranging between 0.1 μM and 1 μM.
In Vivo: Humanized mice reconstituted with human lymphoid cells provide rapid, reliable, reproducible experimental systems for testing the efficacy of ABX464 in vivo. In the initial setting, SCID mice are reconstituted with PBMCs and then infected with the HIV-1 strain JR-CSF. Mice are treated twice a day (b.i.d) for 15 days by oral gavage with 20 mg/kg of ABX464. Measures of viral RNA show that the oral treatment with ABX464 is able to significantly reduce the viral load over a period of 15 days of treatment. FACS analysis of blood samples show that treatment with ABX464 prevents depletion of CD4+ cells following infection of reconstituted mice and thereby restores the CD8+/CD4+ ratio back to that of non-infected mice.
相關(guān)產(chǎn)品：Drug Repurposing Compound Library | Anti-Infection Compound Library | Anti-Virus Compound Library | Clinical Compound Library | Clinical Compound Library Plus | Drug Repurposing Compound Library Plus | Bioactive Compound Library Plus | Dolutegravir | Maraviroc | Cenicriviroc | Ritonavir | Ebselen | Bictegravir | Tenofovir Disoproxil Fumarate | Lamivudine | Efavirenz | Atazanavir sulfate | Raltegravir potassium salt | Tipranavir | Triciribine | Mavorixafor trihydrochloride | Elvitegravir | Saquinavir | Betulinic acid | Zidovudine | Delavirdine mesylate | Miltefosine | Nelfinavir Mesylate | TAK-779 | Lopinavir | Abacavir | Cabotegravir | Etravirine | Nevirapine | Stavudine
采購(gòu)中心
化工儀器網(wǎng)